The invention relates to an antibody that is capable to bind the O-GlcNAcylated tau isoform 2N4R at serine 400. Another object of the invention concerns the use of said antibody for screening molecules for OGA inhibitory activity, and a method for administering a therapeutic molecule to a patient in need of treating Alzheimer's disease. The invention also relates to a method for preparing a monoclonal rabbit antibody.
申请公布号
WO2014159244(A2)
申请公布日期
2014.10.02
申请号
WO2014US22660
申请日期
2014.03.10
申请人
MERCK PATENT GMBH;HERING, HEIKE;DHANABAL, MOHANRAJ;ZHANG, MEI